13.93USDMkt Cap: 1.55B USDP/E: —Last update: 2026-05-21
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provid…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 168.3
54.96BEURP/E 21.7
52.53BTRYP/E 27.3
33.63BPLNP/E 21.9
13.36BSEKP/E 40.3
13.24BEURP/E 30.2
12.58BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap1.55B USD
Enterprise Value1.27B USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-144.74M USD
Revenue/Share—
Last Price13.93 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees136
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.00
PEG—
EV/EBITDA-8.03
EV/Revenue—
P/S—
P/B5.66
EPS (TTM)-1.48
EPS (Forward)-1.27
52W Range
13.1995% of range13.97
52W High13.97 USD
52W Low13.19 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.41%
ROA-43.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-123.34M USD
CapEx (TTM)138.00K USD
FCF Margin—
FCF Yield-4.62%
Net Debt-274.14M USD
Net Debt/EBITDA1.73
Balance Sheet
Debt/Equity0.02
Current Ratio17.85
Quick Ratio17.53
Book Value/Sh2.460 USD
Cash/Share2.516 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)23.40 USD
Target Range19.00 USD – 34.00 USD
# Analysts10
Ownership
Shares Out.111.19M
Float83.53M
Insiders7.91%
Institutions105.14%
Short Interest
Short Ratio13.1d
Short % Float17.23%
Short % Out.13.31%
Shares Short14.80M
Short (prev mo.)14.23M
Technical
SMA 5015.26 (-8.7%)
SMA 20013.53 (+3.0%)
Beta-0.10
S&P 52W Chg28.31%
Avg Vol (30d)1.00M
Avg Vol (10d)1.27M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—